Get the Stockscreener App
0.7171
0.70%
0.005
Pasithea Therapeutics Corp stock is traded at $0.7171, with a volume of 31,069.
It is up +0.70% in the last 24 hours and down -0.40% over the past month.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).
See More
Previous Close:
$0.7121
Open:
$0.698
24h Volume:
31,069
Relative Volume:
0.06
Market Cap:
$5.34M
Revenue:
-
Net Income/Loss:
$-16.28M
P/E Ratio:
-0.0516
EPS:
-13.91
Net Cash Flow:
$-13.75M
1W Performance:
+2.05%
1M Performance:
-0.40%
6M Performance:
-44.84%
1Y Performance:
-84.75%
1-Day Range:
$0.69
$0.725
1-Week Range:
$0.6893
$0.7321
52-Week Range:
$0.65
$7.50
Pasithea Therapeutics Corp Stock (KTTA) Company Profile
Name
Pasithea Therapeutics Corp
Sector
Industry
Phone
(702) 514-4174
Address
1111 LINCOLN ROAD, SUITE 500, MIAMI BEACH
Compare KTTA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KTTA
Pasithea Therapeutics Corp
|
0.7171 | 5.29M | 0 | -16.28M | -13.75M | -13.91 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Pasithea Therapeutics Corp Stock (KTTA) Latest News
Is Pasithea Therapeutics Corp. Equity Warrant reversing from oversold territory2025 Price Momentum & Weekly High Return Stock Forecasts - Newser
Options Data Show Bullish Bias in Pasithea Therapeutics Corp.Portfolio Value Report & Consistent Profit Focused Trading Strategies - newsyoung.net
How to integrate Pasithea Therapeutics Corp. into portfolio analysis toolsStop Loss & Daily Stock Trend Reports - Newser
What’s the recovery path for long term holders of Pasithea Therapeutics Corp.July 2025 Closing Moves & Safe Capital Growth Stock Tips - Newser
Historical volatility pattern of Pasithea Therapeutics Corp. Equity Warrant visualizedQuarterly Trade Review & Growth Focused Entry Reports - Newser
Heatmap analysis for Pasithea Therapeutics Corp. Equity Warrant and competitorsTrade Risk Report & Daily Stock Trend Reports - Newser
Leading vs lagging indicators on Pasithea Therapeutics Corp. performance2025 Price Momentum & Risk Controlled Stock Alerts - Newser
Is Pasithea Therapeutics Corp. Equity Warrant stock entering bullish territoryJuly 2025 Opening Moves & Reliable Price Action Trade Plans - Newser
Using data models to predict Pasithea Therapeutics Corp. stock movementPortfolio Performance Report & AI Based Trade Execution Alerts - Newser
What institutional flow reveals about Pasithea Therapeutics Corp.Short Setup & Verified Swing Trading Watchlists - Newser
Can Pasithea Therapeutics Corp. Equity Warrant Overcome Bearish SentimentForecast Cut & Short-Term Trading Alerts - Newser
Visual trend scoring systems applied to Pasithea Therapeutics Corp. Equity WarrantEarnings Beat & Safe Swing Trade Setups - Newser
What’s the recovery path for long term holders of Pasithea Therapeutics Corp. Equity Warrant2025 Market Outlook & Intraday High Probability Setup Alerts - Newser
How to escape a deep drawdown in Pasithea Therapeutics Corp. Equity WarrantMarket Activity Report & Safe Entry Momentum Tips - Newser
How to manage a losing position in Pasithea Therapeutics Corp.Jobs Report & Verified Chart Pattern Signals - Newser
Price action breakdown for Pasithea Therapeutics Corp. Equity WarrantGap Down & Free Long-Term Investment Growth Plans - Newser
How moving averages guide Pasithea Therapeutics Corp. Equity Warrant tradingQuarterly Investment Review & Real-Time Buy Zone Alerts - Newser
How to monitor Pasithea Therapeutics Corp. with trend dashboardsMarket Movers & Daily Volume Surge Trade Alerts - Newser
How to read the order book for Pasithea Therapeutics Corp. Equity WarrantJuly 2025 Analyst Calls & Daily Technical Forecast Reports - Newser
Will Pasithea Therapeutics Corp. Equity Warrant stock go up soonMarket Risk Report & Real-Time Volume Trigger Notifications - Newser
Pasithea Therapeutics Corp.’s Beta Climbs After Market Volatility2025 Market Outlook & Risk Controlled Daily Plans - 선데이타임즈
What data driven models say about Pasithea Therapeutics Corp.’s futureJuly 2025 Drop Watch & Consistent Growth Stock Picks - Newser
Will Pasithea Therapeutics Corp. Equity Warrant stock benefit from interest rate changesCPI Data & Daily Oversold Bounce Ideas - Newser
Published on: 2025-08-19 02:19:11 - Newser
Visualizing Pasithea Therapeutics Corp. Equity Warrant stock with heatmaps2025 Valuation Update & Fast Exit Strategy with Risk Control - Newser
Applying big data sentiment scoring on Pasithea Therapeutics Corp. Equity WarrantJuly 2025 Selloffs & Safe Entry Point Identification - Newser
Using flow based indicators on Pasithea Therapeutics Corp. Equity WarrantDollar Strength & Low Drawdown Momentum Ideas - Newser
Why Pasithea Therapeutics Corp. stock attracts strong analyst attention2025 Winners & Losers & AI Driven Stock Reports - Newser
Using Python tools to backtest Pasithea Therapeutics Corp. strategiesSell Signal & Fast Exit and Entry Strategy Plans - Newser
Published on: 2025-08-18 02:44:16 - Newser
Can trapped investors hope for a rebound in Pasithea Therapeutics Corp.Portfolio Performance Report & Fast Entry High Yield Tips - Newser
Published on: 2025-08-17 06:01:40 - Newser
Pasithea Therapeutics Corp. Equity Warrant Flashes Rebound Signal in Oversold ConditionJuly 2025 News Drivers & Accurate Intraday Trading Signals - metal.it
Pasithea Therapeutics Corp Stock (KTTA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Pasithea Therapeutics Corp Stock (KTTA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Marques Tiago | Chief Executive Officer |
May 12 '25 |
Sale |
0.82 |
960 |
792 |
40,001 |
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):